Evaluation of myelitis patients with low-titer anti-MOG positivity according to the 2023 MOGAD diagnostic criteria

Key Points

• Low-titer anti-MOG positivity was found in myelitis patients, correlating with specific neurological symptoms.
• The analysis highlighted a distinction in diagnostic criteria that improves patient classification and management.
• Assessment was based on the 2023 diagnostic criteria, using a comprehensive evaluation of patient symptoms and biomarkers.
• These findings underscore the need for updated criteria, enhancing the understanding of myelitis within the autoimmunity spectrum.